CrystalsFirst GmbH is a startup based in Germany.
CrystalsFirst GmbH provides a platform that leverages patented high-throughput structural biology combined with AI-powered drug design to accelerate small-molecule drug discovery, enabling ligand identification and optimization through structural biology and fragment screening.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.